MedPath
FDA Approval

Abstral

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
ProStrakan, Inc.
DUNS: 014778321
Effective Date
February 29, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Fentanyl(800 ug in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Novartis Consumer Health, Inc.

ProStrakan, Inc.

129836151

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Abstral

Product Details

NDC Product Code
42747-228
Application Number
NDA022510
Marketing Category
NDA (C73594)
Route of Administration
SUBLINGUAL
Effective Date
January 21, 2011
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
FentanylActive
Code: MUN5LYG46HClass: ACTIMQuantity: 800 ug in 1 1
© Copyright 2025. All Rights Reserved by MedPath